心脏重塑和功能变化在患有多变心肌病的患者:一个纵向观察性研究
Shabarnadh Reddy1, Dharma Teja2, Rithvika R3
1Department of General Medicine, Narayana Medical College, Nellore, IND.
Cureus
|November 8, 2023
概括
增高性心肌病 (HCM) 在24个月内呈现逐渐的心脏重塑. 在HCM患者中,β-阻断剂治疗可能会减缓左心室壁加厚.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 内部医学 内部医学
背景情况:
- 增高性心肌病变 (HCM) 是一种遗传性心脏病,导致左心室肌动脉变厚.
- 这种情况可能会导致严重的临床问题,包括突然的心脏病死亡.
研究的目的:
- 随着时间的推移,跟踪心脏重塑和功能变化在多变性心肌病 (HCM) 患者.
- 评估不同的治疗方法如何影响HCM的进展.
主要方法:
- 在100名HCM患者的24个月前性纵向观察研究中.
- 收集了基线数据 (人口统计,病史,心声) 并定期进行后续评估.
- 利用统计分析,包括配对的t测试和子组分析,以评估变化和治疗组差异.
主要成果:
- 患者的左心室壁厚度 (每年1.0毫米),左心房尺寸 (每年3.0毫米) 和心室质量 (每年8克) 逐渐增加.
- 扩张和收缩功能下降,以降低E/A比率 (-0.1单位/年) 和减少射出分数 (-2.0%每年) 为证据.
- 贝塔抑制剂治疗与左心室壁加厚率降低相关.
结论:
- 纵向数据显示HCM患者正在进行心脏重塑和功能衰退.
- 这些发现有助于人们更好地了解海的自然历史.
- 贝塔抑制剂治疗显示出缓解左心室缩进展的潜力,指导未来的治疗策略.
更多相关视频
相关概念视频
Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Cardiomyopathy III: Hypertrophic Cardiomyopathy
15
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
15
Heart Failure II: Pathophysiology
14
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Cardiomyopathy IV: Restrictive Cardiomyopathy
12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12


